Dr Catherine Carmichael joins ACBD

Dr Catherine Carmichael

Welcome to Dr Catherine Carmichael from the Walter and Eliza Hall Institute (WEHI), whose expertise is on the regulation of both normal and abnormal blood cell development especially in relation to leukaemia. Dr Carmichael received her PhD from the University of Melbourne in 2008, studying genetic predispositions to haematological malignancies. She was a postdoc for 6 years at WEHI studying the role of the ETS-related gene, ERG, during leukaemia development. She has now joined the Australian Centre for Blood Diseases Mammalian Functional Genetics lab of A/Prof Jody Haigh as a Research Fellow, and is studying the role of Epithelial-Mesenchymal Transition (EMT) modulators during both normal blood cell production ("haematopoiesis") and leukaemia development. See more at www.acbd.monash.org/research/mammal-genetics.html